Microbubble contrast agents: Targeted ultrasound imaging and ultrasound-assisted drug-delivery applications

Investigative Radiology

Volumn 41, Issue 3, 2006, Pages 354-362

  Klibanov, Alexander L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Drug delivery; Echo contrast; Microbubbles; Targeted contrast; Ultrasound; Ultrasound contrast

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ECHO CONTRAST MEDIUM; FIBRINOLYTIC AGENT; IRON OXIDE; LIPOSOME; MACROGOL; NC 100100; PERFLEXANE; PLASMID DNA; POLYSTYRENE; RECEPTOR; RECOMBINANT DNA; SHU 508; SONOVIST; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; CONTRAST MEDIUM;

ANGIOGENESIS; DISSOLUTION; DRUG ACTIVATION; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG STABILITY; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; ISCHEMIA; LIVER DISEASE; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPERFUSION INJURY; REVIEW; SENSITIVITY ANALYSIS; SURFACE TENSION; THROMBOSIS; TISSUE CHARACTERIZATION; TISSUE PERFUSION; ULTRASOUND; VASCULAR ENDOTHELIUM; ANIMAL; CLINICAL TRIAL; ECHOGRAPHY; PLASMID; VASCULAR DISEASE;

ANIMALS; CLINICAL TRIALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MICROBUBBLES; PLASMIDS; ULTRASONOGRAPHY; VASCULAR DISEASES;

EID: 33745924402     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000199292.88189.0f     Document Type: Review

References (86)

1. Li KC, Bednarski MD. Vascular-targeted molecular imaging using functionalized polymerized vesicles. J Magn Reson Imaging. 2002;16:388-393.
2. Kelloff GJ, Sigman CC. New science-based endpoints to accelerate oncology drug development. Eur J Cancer. 2005;41:491-501.
3. Dittmar KM, Xi J, Hunter F, et al. Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology. 2005;235:541-546.
4. Mizushige K, Kondo I, Ohmori K, et al. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure. Ultrasound Med Biol. 1999;25:1431-1437.
5. Bekeredjian R, Grayburn PA, Shohet RV. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol. 2005;31:687-691.
6. Epstein PS, Plesset MS. On the stability of gas bubbles in liquid-gas solutions. J Chem Phys. 1950;18:1505-1509.
7. Gramiak R, Shah SP. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-366.
8. Bommer W, Weinert L, Neumann A, et al. Determination of right atrial and right ventricular size by two-dimensional echocardiography. Circulation. 1979;60:91-100.
9. Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent - results of a phase III multicenter trial. J Am Coll Cardiol. 1998;32:746-752.
10. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles - demonstration and potential mechanisms. Circulation. 1995;92:2391-2395.
11. Christiansen C, Kryvi H, Sontum PC, et al. Physical and biochemical characterization of Albunex, a new ultrasound contrast agent consisting of air-filled albumin microspheres suspended in a solution of human albumin. Biotechnol Appl Biochem. 1994;19:307-320.
12. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995;30:451-457.
13. Klibanov AL, Gu H, Wojdyla JK, et al. Attachment of ligands onto the gas-filled microbubbles via PEG spacer arm and lipid residues anchored at the interface. In: Proceedings of 26th International Symposium on Controlled Release of Bioactive Materials.Boston: Controlled Release Society; 1999:124:-125.
14. Kim DH, Klibanov AL, Needham D. The influence of tiered layers of surface-grafted poly(ethylene glycol) on receptor-ligand-mediated adhesion between phospholipid monolayer-stabilized microbubbles and coated class beads. Langmuir. 2000;16:2808-2817.
15. Narayan P, Wheatley MA. Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. Polymer Eng Sci. 1999;39:2242-2255.
16. Hauff P, Reinhardt M, Briel A, et al. Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology. 2004;231:667-673.
17. Villanueva FS, Gertz EW, Csikari M, et al. Detection of coronary artery stenosis with power Doppler imaging. Circulation. 2001;103:2624-2630.
18. Bouakaz A, Versluis M, de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol. 2005;31:391-399.
19. Bloch SH, Wan M, Dayton PA, et al. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett. 2004;84:631-633.
20. Bloch SH, Short RE, Ferrara KW, et al. The effect of size on the acoustic response of polymer-shelled contrast agents. Ultrasound MedBiol. 2005;31:439-444.
21. Ryan P, Davis M, Melchior D. Liposomes containing modified cholesterol for organ targeting. USA Patent. 4544545. 1985.
22. Alkan-Onyuksel H, Demos SM, Lanza GM, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci. 1996;85:486-490.
23. Demos SM, Alkan-Onyuksel H, Kane BJ, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. 1999;33:867-875.
24. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43:453-460.
25. Huang SL, Hamilton AJ, Pozharski E. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol. 2002;28:339-348.
26. Klibanov AL, Hughes MS, Marsh JN, et al. Targeting of ultrasound contrast material - an in vitro feasibility study. Acta Radiol. 1997;38:113-120.
27. Klibanov AL, Hughes MS, Wojdyla JK, et al. Targeting of ultrasound contrast material: selective imaging of microbubbles in vitro. Acad Radiol. 1998;5:S243-S246.
28. Klibanov AL, Hughes MS, Villanueva FS, et al. Targeting and ultrasound imaging of microbubble-based contrast agents. Magma. 1999;8:177-84.
29. Klibanov AL, Rasche PT, Hughes MS, et al. Detection of individual microbubbles of ultrasound contrast agents - imaging of free-floating and targeted bubbles. Invest Radiol. 2004;39:187-195.
30. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation. 1998;98:1-5.
31. Takalkar AM, Klibanov AL, Rychak JR, et al. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release. 2004;96:473-482.
32. Weller GER, Villanueva FS, Klibanov AL, et al. Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium. Ann Biomed Eng. 2002;30:1012-1019.
33. Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjugate Chem. 2005;16:9-17.
34. Jeppesen C, Wong JY, Kuhl TL, et al. Impact of polymer tether length on multiple ligand-receptor bond formation. Science. 2001;293:465-468.
35. Kono Y, Steinbach GC, Peterson T, et al. Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. Radiology. 2002;224:253-257.
36. Kindberg GM, Tolleshaug H, Roos N, et al. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res. 2003;312:49-54.
37. Fisher NG, Christiansen JP, Klibanov AL, et al. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol. 2002;40:811-819.
38. Albrecht T, Blomley MJK, Heckemann RA, et al. Stimulated acoustic emission with the ultrasound contrast agent levovist: a clinically useful contrast effect with liver-specific properties. Rofo-Fortschr Rontg. 2000;172:61-67.
39. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104:2107-2112.
40. Weller GER, Lu EX, Csikari MM, et al. Ultrasound contrast microbubbles targeted to ICAM-1 detect acute heart transplant rejection. Circulation. 2002;106:378.
41. Kondo I, Ohmori K, Oshita A, et al. Leukocyte-targeted myocardial contrast echocardiography can assess the degree of acute allograft rejection in a rat cardiac transplantation model. Circulation. 2004;109:1056-1061.
42. Unger E, Metzger P, et al. The use of a thrombus-specific ultrasound contrast agent to detect thrombus in arteriovenous fistulae. Invest Radiol. 2000;35:86-89.
43. Schumann PA, Christiansen JP, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 2002;37:587-593.
44. Leong-Poi H, Christiansen JP, et al. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation. 2003;107:455-460.
45. Ellegala DB, Leong Poi H, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta(3). Circulation. 2003;108:336-341.
46. Weller GE, Wong MK, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res. 2005;65:533-539.
47. Christiansen JP, Leong-Poi H, Klibanov AL, et al. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation. 2002;105:1764-1767.
48. Takeuchi H, Ohmori K, Kondo I, et al. Interaction with leukocytes: phospholipid-stabilized versus albumin-shell microbubbles. Radiology. 2004;230:735-742.
49. Sakuma T, Sari I, Goodman CN, et al. Simultaneous integrin alpha(V) beta(2) and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty. Cardiovasc Res. 2005;66:552-561.
50. Leong-Poi H, Christiansen J, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation. 2005;111:3248-3254.
51. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nature Rev Drug Discov. 2004;3:527-532.
52. Rychak JJ, Klibanov AL, Leppanen A, et al. Enhanced binding of ultrasound contrast microbubbles targeted to P-selectin using a physiological capture ligand. FASEB J. 2004;18:A446.
53. Dayton PA, Pearson D, Clark J, et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alpha(v) beta(3)-expressing cells. Mol Imaging. 2004;3:125-134.
54. Rychak JJ, Klibanov AL, Hossack JA. Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Transact Ultrason Ferroelect Freq Control. 2005;52:421-433.
55. Weller GE, Tom EM, Felix MM, et al. Multi-targeting enhances adhesion of ultrasound contrast microbubbles to inflammatory endothelium. Circulation. 2003;108:516.
56. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation. 2004;110:3378-3383.
57. Walter GA, Cahill KS, Huard J, et al. Noninvasive monitoring of stem cell transfer for muscle disorders. Magn Res Med. 2004;51:273-277.
58. Lindner JR, Dayton PA, Coggins MP, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation. 2000;102:531-538.
59. Dayton PA, Chomas JE, Lum AF, et al. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J. 2001;80:1547-1556.
60. Tachibana K, Tachibana S. Further enhancement of fibrinolysis by ultrasound in the presence of echo contrast material. Circulation. 1993;88:163.
61. Tachibana K, Tachibana S. Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation. 1995;92:1148-1150.
62. Tachibana K, Tachibana S. Prototype therapeutic ultrasound emitting catheter for accelerating thrombolysis. J Ultrasound Med. 1997;16:529-535.
63. Xie F, Tsutsui JM, Lof J, et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31:979-985.
64. Matsunaga TO. Ultrasound-mediated therapies using bubble technology: an update. In: 25th Proceedings of Leading Edge in Diagnostic Ultrasound Annual Conference. Atlantic City, NJ. 2005.
65. Culp WC, Porter TR, Lowery J, et al. Intracranial clot lysis with intravenous microbubbles and transcranial ultrasound in swine. Stroke. 2004;35:2407-2411.
66. Price RJ, Skyba DM, Kaul S, et al. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation. 1998;98:1264-1267.
67. Song J, Chappell JC, Qi M, et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol. 2002;39:726-731.
68. Wible JH, Galen KP, Wojdyla JK, et al. Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats. Ultrasound Med Biol. 2002;28:1535-1546.
69. Hwang JH, Brayman AA, Reidy MA, et al. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med Biol. 2005;31:553-564.
70. Unger EC, McCreery TP, Sweitzer RH, et al. Acoustically active lipospheres containing paclitaxel - a new therapeutic ultrasound contrast agent. Invest Radiol. 1998;33:886-892.
71. Unger EC, Hersh E, Vannan M, et al. Gene delivery using ultrasound contrast agents. Echocardiogr. 2001;18:355-361.
72. Christiansen JP, French BA, Klibanov AL, et al. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol. 2003;29:1759-1767.
73. Bekeredjian R, Chen S, Frenkel PA, et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation. 2003;108:1022-1026.
74. Eder IE, Haag P, Bartsch G, et al. Gene therapy strategies in prostate cancer. Curr Gene Ther. 2005;5:1-10.
75. Porter TR, Iversen PL, Li S, et al. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Ultrasound Med. 1996;15:577-584.
76. Schneider M, Yan F, Hiver A. Delivery of biologically active substance to target sites in the body of patients. USA Patent no. 6258378. 2001.
77. Klibanov AL, Rinkevich D, McConaughy JE, et al. Ultrasound-triggered release of microbubble-associated material: site-targeted drug release and deposition. In: 32nd Annual Symposium on Controlled Release of Bioactive Materials. Honolulu: Controlled Release Society; 2004;735.
78. Lewis CW, McConaughy JE, Rinkevich D, et al. Development of a novel microbubble agent for ultrasound-mediated targeted drug delivery. Circulation. 2004;110:511.
79. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature. 2003;423:153-156.
80. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24.
81. Seemann S, Hauff P, Schultze-Mosgau M, et al. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm Res. 2002;19:250-257.
82. Hauff PS, Reszka R, Schultze-Mosgau M, et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology. 2005;236:572-578.
83. Shortencarier MJ, Dayton PA, Bloch SH, et al. A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Transact Ultrason Ferroelect Freq Control. 2004;51:822-831.
84. Dayton P, Klibanov A, Brandenburger G, et al. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol. 1999;25:1195-1201.
85. Klibanov AL, Hughes MS, Wojdyla JK, et al. Direct video microscopic observation of the dynamic effects of medical ultrasound on ultrasound contrast microspheres. Invest Radiol. 1998;33:863-870.
86. Champeneri S, Taylor S, Klibanov A, et al. Gene-loading of targeted microbubbles does not adversely influence binding efficacy. J Am Coll Cardiol. 2005;45:272a.